GLP-1 Drugs Like Ozempic Linked to Rare Blinding Disease

In an observational retrospective study, researchers found that patients with type 2 diabetes or obesity who were taking semaglutide were more likely to develop a rare blinding condition than those taking a non-GLP-1 drug.

July 8, 2024   TODAY'S TOP STORY GLP-1 Drugs Like Ozempic Linked to Rare Blinding Disease READ ON   SPECIAL FEATURE 7 Intermittent Fasting Myths Debunked by Dietitians READ ON   Everything You Need to Know About Diverticulitis READ ON   CBD Oil for COPD: Evidence and Research READ ON MORE STORIES RESOURCE FOR YOU With Bezzy Psoriasis, you're never alone.   Join others who understand what you're going through, and discover a safe space for community, guidance, and support to manage Psoriasis symptoms together. LEARN MORE Bezzy and Healthline are owned by RVO Health.   HEALTHLINE VIDEO     WATCH NOW         HEALTHLINE RESOURCE Hunger Cues With Abbey Sharp   Do you ever find that no matter how much you eat, you're never full? Learn more about this from Abbey Sharp, a registered dietician. LEARN MORE What we're reading next • Drinks to Sip or Skip with Psoriatic Arthritis: Coffee, Alcohol, and More • How to Travel with Wegovy • Does Medicare Cover Breast Reduction Surgery? • What to Know About Nonsustained Ventricular Tachycardia Until then, Take care of yourself, and we'll see you again soon! View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy   |   Unsubscribe Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health. © 2024 RVO Health 1101 Red Ventures Drive Fort Mill, SC 29707